Illumina News and Research

RSS

Illumina named as defendant in patent infringement suits

Illumina, Inc. (NASDAQ:ILMN) released the following statement by Jay Flatley, its Chief Executive Officer, in response to new patent infringement suits filed yesterday by Affymetrix in Delaware, the United Kingdom and Germany. As of this time, Illumina has yet to be served with these suits.

From Illumina, Inc. 25 Oct 2007

Illumina launches MicroRNA assay for gene expression profiling

Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.

From Illumina, Inc. 22 Oct 2007

Cause of major subtype of glaucoma discovered

In a paper published in the journal Science, scientists from deCODE genetics and academic colleagues from the National University Hospital in Reykjavik and Uppsala University in Sweden report the discovery of two common single letter variations (SNPs) in the sequence of the human genome that appear to account for virtually all cases of a major subtype of glaucoma.

12 Aug 2007

What makes people susceptible to rheumatoid arthritis?

Peter K. Gregersen, MD, stares at x-rays of hands, searching out the telltale signs of inflamed joints and wrists from his research subjects with rheumatoid arthritis. With these clinical features at his side, he turns to the basic building blocks of life , the human genome , to figure out what makes these people susceptible to the disabling inflammatory condition.

14 Jun 2007

Variation in 3 genes influences risk of age-related macular degeneration

Researchers in Boston have discovered a new common, noncoding variant in the Complement Factor H (CFH) gene that is associated with age-related macular degeneration (AMD), the leading cause of irreversible visual impairment and blindness among persons aged 60 and older.

30 Aug 2006

DNA of human embryonic stem cells is chemically modified in a characteristic, predictable pattern

Embryonic stem cells are derived from embryos that are undergoing a period of intense cellular activity, including the chemical addition of methyl groups to specific DNA sequences in a process known as DNA methylation.

6 Aug 2006

Genome Quebec Innovation Centre has announced the signing of a service agreement with GenoMed

The McGill University and Genome Quebec Innovation Centre has announced the signing of a service agreement with GenoMed, a US company located in St. Louis, Missouri that specializes in using genomics to practice better medicine.

19 May 2004